Checkmate Pharmaceuticals, Inc. Free Cash Flow 2020-2022 | CMPI
Checkmate Pharmaceuticals, Inc. free cash flow from 2020 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Checkmate Pharmaceuticals, Inc. Annual Free Cash Flow |
| 2021 |
-54.56 |
| 2020 |
-38.11 |
| 2019 |
-26.85 |
| 2018 |
-20.42 |
| Checkmate Pharmaceuticals, Inc. Quarterly Free Cash Flow |
| 2022-03-31 |
-10.67 |
| 2021-12-31 |
-54.56 |
| 2021-09-30 |
-44.40 |
| 2021-06-30 |
-30.07 |
| 2021-03-31 |
-14.31 |
| 2020-12-31 |
-38.11 |
| 2020-09-30 |
-27.42 |
| 2020-06-30 |
-16.04 |
| 2020-03-31 |
-8.25 |
| 2019-12-31 |
-26.85 |
| 2019-09-30 |
-20.26 |
| 2019-06-30 |
-14.71 |
| 2019-03-31 |
-7.83 |
